David B. Miklos

1 ta ish

Memorial Sloan Kettering Cancer Center

1. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

   Frederick L. Locke, David B. Miklos, Caron A. Jacobson +28

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.319265